Making Positive Difference To Lives Across The GlobeALKEM LABORATORIES

Vision

To achieve value driven leadership in Indian Health Care Industry and

beyond through

“Quality that is infinite”“Service that cares”

“Hardwork that endures”.

Goal

To be one of the

Top 3 Companies in India

and also be a successful global

Company through innovations and strategic alliances

Visionary Founder and Chairman

Managing Director

4 Decades Of Giant Strides

Turnover Rs 1,293 cr

Ranked No. 5 in the Indian Pharma Industry

Enjoys high respect from Medical profession & trade in India

The Pharma Major since 1973…

Reputed for building mega brands

4 Decades Of Giant Strides

Buoyant organic growth due to excellent marketing and sales

On the path of rapid globalisation

Products exported to 60 countries

…… moving ahead to become one of the top 3 Indian companiesmoving ahead to become one of the top 3 Indian companies

Sales Break Up Acute And Chronic Segments

93%93%Acute SegmentAcute Segment

7%7%ChronicChronic

SegmentSegment

Total Sales Turnover

Val in Mn US$

 Year 2005-06 2006-07 2007-08 2008-09 2009-10

Total Sales 169 226 239 272 318

2009 - 10 Domestic Sales

SBU’s Value(in Crs)

692.95

150.91

95.73

13.79

111.08

21.72

27.75

15.05

29.70

6.82

Alkem Institution 6.34

Exports 121

Total (App.) 1293

Pentacare

Main Division

Bergen

Ulticare

Generic

Cytomed

Derma CareAlkem Pharma

Mediva

Alkem Health Foods

Top 10 Domestic Company

1. CIPLA 2. RANBAXY 3. GLAXO SMITHKLINE 4. ZYDUS CADILLA 5. NICHOLAS PIRAMAL 6. SUN 7. PFIZER 8. ALKEM 9. MANKIND 10. LUPIN

Growth Rate of Company

Mankind – 37% Pfizer – 33% Sun – 26% ALKEM – 23% Zydus Cadila – 23% Aristo – 20% Cipla - 18 % Glaxo Group - 17% Lupin - 16% Ranbaxy - 11%

ALKEM -A Brand Building Company

Taxim (Cefotaxime) – a flagship brand is among the top 15 brands

of Indian Pharmaceutical Industry

11 other brands in the list of top 300 mega brands

No. 1 in Cephalosporins

Front runners in Co-AmoxyClav and Quinolone segments

Brands In Top 300 Of Indian Pharma Market

Rank Val in Cr.

11 131.72

15 105.88

30 87.27

74 57.63

82 51.94

83 51.89

94 45.53

117 40.82

145 36.84

168 32.92

232 27.29

Sumo ( NSAID)

Xone (Ceftriaxone)

Taxim (Cefotaxime)

Taxim-O (Cefixime)

Clavam (Co-Amoxyclav)

A TO Z (Multi Vitamin/Anti-oxidants)

Gemcal (Calcitrol)

Hemfer (Hematinic)

Pan - D

ORG Mat May 2010

Pan

Ondem

ALKEM in Cephalosporins

Company RankValue

(in Cr.)% MS % Gr

Market 3185.96 17

ALKEM 1 396.85 12.5 7

Aristo 2 271.72 8.5 25

Ranbaxy 3 246.63 7.7 17

ORG Mat May 2010

ALKEM in Co-AmoxyClav

ORG Mat May 2010

Company RankValue

(in Cr.)% MS % Gr

Market 634.07 35

Glaxo Smithkline 1 154.21 24.43 31

ALKEM 2 93.95 14.8 33

Mankind 3 70.27 11 20

ALKEM in Quinolones

ORG Mat May 2010

Company RankValue

(in Cr.)% MS % Gr.

Market 972.71 4

Ranbaxy 1 191.26 19.7 14

Cipla 2 146.58 15.11 7

Mankind 3 72.02 7.4 14

ALKEM 8 31.61 3.2 26

Firsts From Alkem

First Indian Company To Develop, Manufacture & Market These Products In India

• Anaestrazole• Cefotaxime + Sulbactam• Satranidazole• Ceftriaxone + Tazobactam• Cefixime + Clavulanic Acid

First Company To Market These Products In India

• MEROPENAM• CEFEPIME

Important New Products Launched

• Cefixime + Clavulanic AcidCefixime + Clavulanic Acid

• Ceftriaxone + TazobactamCeftriaxone + Tazobactam

• Pantaprazole + ItopridePantaprazole + Itopride

• Aceclofenac RangeAceclofenac Range

• Rabeprazole + DiclofenacRabeprazole + Diclofenac

• MeropenamMeropenam

• CefipimeCefipime

• Piperacillin + TazobactamPiperacillin + Tazobactam

• Cefotaxime + SulbactamCefotaxime + Sulbactam

• Cefprozil

• Gatifloxacin

• Cefpodoxime Proxetil

• Rabeprazole

• Rabeprazole + Domperidone

• Sodium Feredetate

• Donepezil

Important New Products Launched

• Atorvastatin + EzetemibeAtorvastatin + Ezetemibe

• Pioglitazone + MetforminPioglitazone + Metformin

• Metformin SRMetformin SR

• GlimepirideGlimepiride

• EsCitalopramEsCitalopram

• MirtazapineMirtazapine

• QuetiapineQuetiapine

• NebivololNebivolol

• Levo CetirizineLevo Cetirizine• AripiprazoleAripiprazole• BicalutamideBicalutamide• Natural Micronised Natural Micronised

ProgesteroneProgesterone• AnaestrazoleAnaestrazole• PaclitaxelPaclitaxel

NATURAL PRODUCTSNATURAL PRODUCTS • PycnogenolPycnogenol

INTERESTING NUTRACEUTICAL INTERESTING NUTRACEUTICAL PRODUCTSPRODUCTS

• Protein DiskettesProtein Diskettes• Meal Replacer BarsMeal Replacer Bars• Nutraceutical soupsNutraceutical soups

Our Core Strengths

Focussed SBUs

Technical Expertise

People

Logistics

Finance

Focussed SBUS

Focused SBU’s

Main Pharma Division

Ulticare

Bergen

Pentacare

Mediva

Cytomed

Derma Care

Therapy Representation Of SBU’s

Main PharmaMain Pharma

• Anti-infectiveAnti-infective

• GastroenterologyGastroenterology • Gynecology Gynecology

• Pediatric Pediatric

• Surgery Surgery

• NutraceuticalsNutraceuticals

• Nsaids Nsaids

• UrologyUrology

UlticareUlticare• Anti-infectiveAnti-infective• Nutraceuticals Nutraceuticals • Anti-tuberculosisAnti-tuberculosis• Special Focus - PaediatricsSpecial Focus - Paediatrics

BergenBergen • Anti‑infectiveAnti‑infective• Orthopedics Orthopedics • NutraceuticalsNutraceuticals• DermatologyDermatology

DermacareDermacare Skin Care DivisionSkin Care Division

Therapy Representation Of SBU’s

PentacarePentacare

• Anti‑parkinson's Anti‑parkinson's

• Anti-depressantsAnti-depressants

• Anti-psychotics Anti-psychotics

• Anxiolytics Anxiolytics

• Anti-epileptics Anti-epileptics

• Anti‑alzheimer'sAnti‑alzheimer's

CytomedCytomed• Anti-cancer Anti-cancer

• Anti retroviralsAnti retrovirals

MedivaMediva

• Cardio Vascular & Anti Cardio Vascular & Anti Diabetic RangeDiabetic Range

Diversified Business

Alkem Health Foods :Alkem Health Foods :• Jeevan prash – a tasty, Low Calorie & sugar free chyawanprashJeevan prash – a tasty, Low Calorie & sugar free chyawanprash

• Blocal – Low Calorie SweetnerBlocal – Low Calorie Sweetner

• Tammy :Tammy :

• Salt Substitute, Fat Substitutes and Sucralose based products – Salt Substitute, Fat Substitutes and Sucralose based products – Jams, Cookies, Jelly, Juices & cakes (Calorie Conscious and Jams, Cookies, Jelly, Juices & cakes (Calorie Conscious and Diabetics), Cholesterol free edible Oil.Diabetics), Cholesterol free edible Oil.

Technical Expertise

The Research And Development Centre Active In Almost All Facets Of The Business

R&D centre at Mumbai approved by DSIR

Formulation development for domestic market

Formulation development for MAA/ANDA program

Process development group for APIs and nutraceuticals

Fully equipped modern state-of-the-art labs

Sophisticated information services

7 World class manufacturing facilities

2000 Million units of Tablets per annum

200 Million units of Capsules p.a

500 Million units of Injectable p.a

60 Million units of Liquids p.a

600 Million units of dry syrups p.a

30 Mn Units of I.V. infusions p.a30 Mn Units of I.V. infusions p.a..

State-of-the Art Manufacturing Committed To International Quality Compliance

Manufacturing Locations

Daman – Amailya and Kachigam Plant

Gujrat -Mandava and Ankaleshwar Plant

Himachal Pradesh – Baddi

Sikkim - Rangpo

Contract Research Organization( Phoenix Bio-Pharma Research Centre )

Conforming to International standards

Bio- equivalence studies

Drug Metabolism Pharmacokinetics

Method Development / Method Validation etc.

Post Marketing Surveillance

Independent Ethics Committee comprising of well known

personalities eg. Dr. H.P. Tipnis

Low cost for studies as compared to the west

People

ALKEM – Our People

Cohesive team of professionals with a proven track record and complementary skills

Well Trained, Competent and Dedicated field force across the country

Creative & Vibrant strategic Marketing Team with experience of building mega brands

Competent pool of Scientists, Pharmacists & Technologists

Over 6000 employees

Our Values

Honesty and Integrity Respect/care & concern for people Customer Orientation Commitment to Quality Learning Organization Dedication and Commitment Trust Teamwork Openness and Transparency Discipline Result Oriented

Logistics

Selling & Distribution Channels

• Depots: 24

• C&F: 4

• Warehouse : 4

• 3000 Field Force spanning the entire country

• 1,40,000 retailer coverage

• 3,65,000 Doctor coverage ( 40 % of universe )

Finance

Negligible Debt; Major Project Cost and Expansion Programs met

out of Retained Earnings

Low Borrowing Cost, Interest Cost progressively becoming nil, Net

Income generated on the Interest Front

Owns substantial Properties and Tangible Assets

Tax Planning, Profit Tax free subject to MAT

Liquidity

Accumulated Cash Reserves and Surplus

Surplus available for Expansion, R&D and M&A Activity

Financial Strength

International Footprint

Key Attributes

Excellent growth in exports in last 3 years

 

Currently exports to more than 60 countries

Exports to regulated markets in Europe including UK

1.   Marketing through agent network in Unregulated and Semiregulated markets

2.  Regulated Markets

Toll manufacture for large generic companies in Highly regulated markets like Europe, South Africa, Australia & USA

Own European filings & US ANDA’s

Strategic Alliances , Acquisitions & JV’s

Strategic Approach

Contract manufacturing for generic companies in regulated European Market

Alliance with other European and American generic major`s in process

Tie-up for innovative nutraceuticals and food products in process

Strategic Alliance

Cephalosporin Block – Oral & Injectable (Daman)

Approved by UK MHRA ( orals & injectable )

Approved by MCC, south Africa ( orals & injectable )

Approved by ANVISA, brazil (injectable)

 Beta lactam block (daman)

Approved by ANVISA brazil (injectables )

Successfully inspected by UKMHRA ( Oral & Injectable)

– approval expected shortly

General block facility (daman)

Approved by USFDA & UKMHRA( ORAL ) and also approved by ANVISA Brazil

USFDA Process for all the three Blocks has been initialized and completed

REGULATORY APPROVALS

Our New Ventures

Sucralose

Developed a cost effective , environment friendly, patent non infringing process

Confirms to USP-NF specifications

Certified by CFTRI & BAJAJ centre

Dedicated facility based on regulated market requirements Capacity : 10 tonnes/month

Foray Into Biotechnology

First Phase : HUMAN INSULIN EPO

GCSF INTERFERO

(GERMAN ASSOCIATION)

Looking Ahead…

MAAs in European Market

ANDAs in USA

Contract manufacturing for generic companies in regulated European

Market

In licensing arrangement for marketing PATENTED molecules in India

Strategic alliances, Acquisitions & JVs

Backward integration to API manufacturing.

cGMP lab & pilot plant; futuristic contract research business opportunities

Identifying and Contract research business opportunities

Why you should work with Alkem

We are Growing organization

Fast Career Growth

Performance Driven Organization.

We are growing at the rate of 23 % per annum as compared to the Industry growth rate of 17 %.

Compare to all top rank companies in domestic we are growing at higher rate.

Incentive driven compensation structure.

Believe in Fun at work place.

Web Site

www. alkemlabs.com